ArticleEMBO reports2025
Extracellular matrix-driven metabolic control of pancreatic endocrine lineage allocation.
Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The mechanical and metabolic states of progenitor and stem cells are emerging as key regulators of cell fate decisions. Lineage specification of pancreatic endocrine cells is promoted by reduced mechanical tension in vitro, but the underlying mechanism is poorly understood. Here, we show that heterogeneously deposited low-adhesion extracellular matrix (ECM) components, such as the laminin isoform LN411, trigger a local "soft" environment by broadly reducing the expression of integrins. Mimicking this low-tension state by in vitro knockdown and in vivo gene targeting of the LN-binding integrins Itga3 and Itga6 reveal their importance in inducing endocrinogenesis. Unexpectedly, the cell responds to this change in tensile forces by engaging a major metabolic enzyme, PDK4, to execute the resulting cell fate decision. PDK4 achieves this through two distinct mechanisms: a non-canonical action controlling YAP activity and a canonical metabolic function maintaining PDX1 expression. In sum, we believe our findings have broad relevance for how local changes in mechanical tension governs cell behaviour in many developmental and disease contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.